Senti Bio is seeking an experienced Director to lead our analytical development group for our cell therapy programs. A successful applicant will have prior experience taking a novel cell therapy through IND and be comfortable in a fast moving and nimble culture. Applicants should have current and extensive knowledge of supporting the development of cell products (e.g. CAR T, CAR NK). This role will lead the development of analytical methods for c...
Who we are. Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused o...
